2014 annual financial data
GT Biopharma 2014 Net margin
Direct answer
Net margin was -38,506.56%.
Operating income was -2,396,000 USD and net income was -23,489,000 USD.
Operating cash flow was -1,749,000 USD.
Get free GT Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 61,000 USD
- Operating income
- -2,396,000 USD
- Net income
- -23,489,000 USD
- Operating cash flow
- -1,749,000 USD